Market
Privium Fund Opens $5.07 Million Denali Stake Ahead of FDA Drug Approval
This biotech company develops therapies for neurodegenerative and rare diseases, supported by clinical assets and pharma collaborations.
Was this article helpful?
Community
Loading comments...



